TickerFacts.

Incyte Corp (INCY): Total Liabilities

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2014-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$1.79B
As of 2025-12-31
$1.72B
As of 2026-03-31
+6.8%
3-year compound annual growth
+13.5%
5-year compound annual growth
+7.9%
10-year compound annual growth
$2.00B2010-12-31: $578.23M2011-12-31: $556.04M2012-12-31: $505.38M2013-12-31: $822.68M2014-12-31: $878.11M2015-12-31: $836.28M2016-12-31: $1.22B2017-12-31: $671.95M2018-12-31: $719.79M2019-12-31: $828.34M2020-12-31: $949.65M2021-12-31: $1.16B2022-12-31: $1.47B2023-12-31: $1.59B2024-12-31: $2.00B2025-12-31: $1.79B$1.79B
2010-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.79B-10.3%2026-02-10, Balance as of period end
2024-12-31$2.00B+25.4%2026-02-10, Balance as of period end
2023-12-31$1.59B+8.3%2025-02-10, Balance as of period end
2022-12-31$1.47B+26.4%2024-02-13, Balance as of period end
2021-12-31$1.16B+22.5%2023-02-07, Balance as of period end
2020-12-31$949.65M+14.6%2022-02-08, Balance as of period end
2019-12-31$828.34M+15.1%2021-02-09, Balance as of period end
2018-12-31$719.79M+7.1%2020-02-13, Balance as of period end
2017-12-31$671.95M-44.9%2019-02-14, Balance as of period end
2016-12-31$1.22B+45.8%2018-02-15, Balance as of period end
2015-12-31$836.28M-4.8%2017-02-14, Balance as of period end
2014-12-31$878.11Mn/c2016-02-12, Balance as of period end
2013-12-31$822.68M+62.8%2015-02-17, Balance as of period end
2012-12-31$505.38M-9.1%2014-02-21, Balance as of period end
2011-12-31$556.04M-3.8%2013-02-21, Balance as of period end
2010-12-31$578.23Mn/a2012-02-22, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Incyte Corp (INCY)2025-12-31$1.79B-10.3%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.92B-2.4%
Icon PLC (ICLR)2025-12-31$7.08B-1.6%
Medpace Holdings, Inc. (MEDP)2025-12-31$1.52B+18.9%
Iqvia Holdings Inc. (IQV)2025-12-31$23.31B+11.9%
NRC Health (NRC)2025-12-31$120.89M+19.4%
MaxCyte, Inc. (MXCT)2025-12-31$31.02M-6.6%
OmniAb, Inc. (OABI)2025-12-31$33.89M-10.7%
Foxo Technologies Inc. (FOXO)2025-12-31$33.50M-8.1%

Compare INCY, CRL, ICLR, MEDP side by side · Screen every company in Services-Commercial Physical & Biological Research ↗